LCN2 and prostate carcinoma: LCN2 has also been demonstrated to be up-regulated in human OSCC [17] and in pancreatic, colon, skin, and breast cancers in humans [18–21]; knockdown of LCN2 inhibits the growth and invasiveness of prostate cancer cells [22].